Cirrhosis Care Alberta (CCAB): A Pragmatic Type II Hybrid Effectiveness Implementation Trial

Cirrhosis Care Alberta (CCAB) is a 3 year multi-component system-wide quality improvement trial which aims to improve quality of care, reduce acute care utilization and meet the needs of both patients and providers throughout Alberta. Instead of addressing just a single contributor to acute care utilization, this ambitious intervention will be the first in the world to bring together care providers across the province to tackle the complex multilevel problem with a multilevel solution. The intervention includes implementation of our standardized integrated strategy for delivering evidence-based best practices under real-world conditions to address the key determinants of hospital readmission and length of stay (LOS) in patients admitted with cirrhosis.

The CCAB project intervention includes:

1. Comprehensive Care Bundle (development underway):

1. Admission and Discharge/Transition order set focused on the screening and management of:

* Cirrhosis complications * Frailty and malnutrition * Alcohol use disorder and * Transition to community 2. Patient and caregiver education

• A major theme that came up in focus group work with patients and in the literature is the lack of useful information that is available to them. This is a top priority for patients. Education will include guidelines and tools for patients to improve self-management as well as support for caregivers. 3. Provider education

* Nursing education focused on providing teaching to patients with cirrhosis and initiating alcohol screening and performing a brief intervention to promote abstinence is done in the minority of patients at discharge. * Physician education focused on cirrhosis complications and broader health needs such as prescribing pharmacological therapies for alcohol use disorder (currently done in \<5% of patients even though the number needed to treat is 12 (i.e. need to do it in 12 patients to result in a benefit)). 2. Community Care Pathways

1. Hepatic Encephalopathy (HE) Pathway: HE is the most common reason for admission to hospital and is a significant burden on patients and families. In collaboration with Health Link, this project aims to develop a call pathway so that patients and families can receive best practice support by nurses in the community and avoid needing to access emergency departments when HE can safely be managed in the community. The patient education surrounding HE is being developed as part of the Care Bundle, but developing a care pathway will ensure the education is translated and reinforced. 2. Ascites Pathway: Ascites (abdominal fluid build-up) is the most common cirrhosis related complication and is extremely uncomfortable for patients. When diuretics are not tolerated or ineffective, this population typically requires frequent draining of the ascites fluid (paracentesis) to treat symptoms such as shortness of breath, pain and inability to eat. Paracentesis is usually performed in hospital based day procedure areas, but when patients can not access a scheduled paracentesis in a timely manner, they are left with no option other than going to emergency rooms. Through process mapping and identifying current barriers and facilitators with each site, the project team aims to develop effective pathways for linking patients in with timely paracentesis.

• Hospital Readmission Rate [Срок оценки: Baseline,through study completion, an average of 1 year]
• Mean Length of Stay (LOS) (Ward, ICU, Total) [Срок оценки: Baseline,through study completion, an average of 1 year]
• Readmission rate at 90 days [Срок оценки: From commencement of the study (baseline), assessed quarterly until study completion.]
• Emergency Department (ED) Visit Rate [Срок оценки: Baseline,through study completion, an average of 1 year]
• Outpatient Visit rate [Срок оценки: Baseline,through study completion, an average of 1 year]
• Survival [Срок оценки: Baseline,through study completion, an average of 1 year]
• Disease severity [Срок оценки: Baseline,through study completion, an average of 1 year]
• Implementation fidelity [Срок оценки: From commencement of the study (baseline), assessed quarterly until study completion.]